Avanos Medical saw the highest growth of 0.99% in patent filings and 2.32% in grants in June in Q2 2024. Compared to Q1 2024, Q2 2024 saw no growth in patent filings and grants by 1.49%. GlobalData’s DataBook provides a comprehensive analysis of Avanos Medical‘s patent filings and grants. Buy the databook here.
Avanos Medical has been focused on protecting inventions in United States(US) with 14 publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 42% filings and 56% grants. The United States(US), Australia(AU), European Patent Office(EPO), and Japan(JP) patent Office are among the top ten patent offices where Avanos Medical is filings its patents. Among the top granted patent authorities, Avanos Medical has 56% of its grants in United States(US), 19% in European Patent Office(EPO) and 12% in Japan(JP).
Boston Scientific and Johnson & Johnson could be the strongest competitors for Avanos Medical
In terms of grant share, Avanos Medical stands in seventh position among its competitors. Boston Scientific and Johnson & Johnson secured the top positions according to recent patent publication data.
Patents related to healthtech and machine learning lead Avanos Medical's portfolio
Avanos Medical has the highest number of patents in healthtech followed by, machine learning and smart hospitals. For healthtech, nearly 50% of patents were filed and 100% of patents were granted in Q2 2024.
General surgery devices related patents lead Avanos Medical portfolio followed by neurology devices, and hospital supplies
Avanos Medical has highest number of patents in general surgery devices followed by neurology devices, hospital supplies, anesthesia and respiratory devices, and packaging. For general surgery devices, nearly 26% of patents were filed and 26% of patents were granted in Q2 2024.
For comprehensive analysis of Avanos Medical's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.